2015
DOI: 10.1016/j.ejps.2015.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
79
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 183 publications
(83 citation statements)
references
References 44 publications
3
79
1
Order By: Relevance
“…37,38 On the other hand, X 1 had a negative effect on Y 5 which could be explained by increasing the particle size and subsequently decreasing the specific surface area and, …”
mentioning
confidence: 99%
“…37,38 On the other hand, X 1 had a negative effect on Y 5 which could be explained by increasing the particle size and subsequently decreasing the specific surface area and, …”
mentioning
confidence: 99%
“…The particle size of the prepared SLN was in the range of 69-223 nm, where the smallest particles were obtained after sonication treatment. Moreover, the examined SLN were characterized by PI values around 0.4 suggesting a broad distribution of the same particles [25]. All zeta potential values were found negative, but in the case of SLN formulated starting from acetic phase the external charge of the SLN was slightly negative for both GSH-SLN (HAc), and sonicated GSH-SLN (HAc), (-4.0 mV and -2.5 mV, respectively).…”
Section: Discussionmentioning
confidence: 95%
“…the exclusion of any chemical modification of GSH, by monitoring its HPLC peak before and after each sonication treatment. In the literature, several examples of sonication applied to solid lipid nanoparticles are reported, either for loading of hydrophilic drug substances [25,29] or hydrophobic ones [30][31][32]. Herein, we have tried to pre-form SLN according to the melt-emulsification technique and as a following step to apply probe-sonication, in an attempt to protect the sensitive molecule of GSH inside a preformed SLN carrier.…”
Section: Discussionmentioning
confidence: 99%
“…[92][93][94][95][96] Initially, SLN-or MSLN-loaded bioactive compounds were given intranasally or intravenously, and these showed extensive bioavailability in the brain, thereby preventing inflammation and further progression of AD. [97][98][99][100][101] Quercetin-loaded SLN with a particle size of about 200 nm was studied for its efficacy in the AD model, and it showed excellent delivery of quercetin to the brain with a higher antioxidative effect in brain cells. 102 The transport of bioactive compounds to the brain occurs through the endocytosis of the brain capillaries, and these compounds can thereby cross the blood-brain barrier.…”
Section: Anti-alzheimer's Effectmentioning
confidence: 99%